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Abstract Pseudoxanthoma elasticum (PXE) is an autoso-
mal recessive disorder in which calcification of connective
tissue leads to pathology in skin, eye and blood vessels.
PXE is caused by mutations in ABCC6. High expression of
this transporter in the basolateral hepatocyte membrane
suggests that it secretes an as-yet elusive factor into the
circulation which prevents ectopic calcification. Utilizing
our Abcc6
−/− mouse model for PXE, we tested the
hypothesis that this factor is vitamin K (precursor) (Borst
et al. 2008, Cell Cycle). For 3 months, Abcc6
−/− and wild-
type mice were put on diets containing either the minimum
dose of vitamin K required for normal blood coagulation or
a dose that was 100 times higher. Vitamin K was supplied
as menaquinone-7 (MK-7). Ectopic calcification was
monitored in vivo by monthly micro-CT scans of the snout,
as the PXE mouse model develops a characteristic
connective tissue mineralization at the base of the whiskers.
In addition, calcification of kidney arteries was measured
by histology. Results show that supplemental MK-7 had no
effect on ectopic calcification in Abcc6
−/− mice. MK-7
supplementation increased vitamin K levels (in skin, heart
and brain) in wild-type and in Abcc6
−/− mice. Vitamin K
tissue levels did not depend on Abcc6 genotype. In
conclusion, dietary MK-7 supplementation increased vita-
min K tissue levels in the PXE mouse model but failed to
counteract ectopic calcification. Hence, we obtained no
support for the hypothesis that Abcc6 transports vitamin K
and that PXE can be cured by increasing tissue levels of
vitamin K.
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PXE is an autosomal recessive disease characterized by
progressive mineralization of connective tissue [1–4].
Clinically important sites of calcification are elastic layers
in skin, Bruch’s membrane of the eye and vascular arteries.
The calcification leads to skin lesions, vision loss and
various cardiovascular complications.
Positional cloning indicated that PXE is caused by
mutations in ABCC6 [5, 6]. Inactivation of Abcc6 in the
mouse resulted in the development of a PXE-like pheno-
type with calcification in eye, skin and blood vessels [7, 8].
This confirmed the role of ABCC6 in PXE and provided us
with an animal model for PXE.
ABCC6 encodes a member of the ABCC family of
organic anion transporters [9]. The protein is prominently
expressed in liver and kidney but virtually absent from the
affected sites [10–12]. In the liver, ABCC6 localizes to the
basolateral membrane of the hepatocyte [7, 13], where it is
supposed to transport its substrate from the cytoplasm into
the circulation. Mutations that impair this transport function
cause PXE [14]. These findings suggested that PXE is a
metabolic disease brought about by changes in circulating
factors that occur when the ABCC6 pump is not function-
ing properly [15]. Recent studies provide strong experi-
mental evidence for this hypothesis. Serum from PXE
patients caused abnormal elastic fibre formation in cultures
of fibroblasts, irrespective of whether fibroblasts were
derived from PXE patients or from unaffected individuals
[16]. Jiang et al. [17] demonstrated that muzzle skin
transplants of Abcc6
−/− mice grafted onto wild-type (wt)
mice remained normal, whereas wt transplants grafted onto
Abcc6
−/− mice developed ectopic calcification.
Several studies implicate vitamin K in the pathophysiol-
ogy of PXE. An intriguing finding was that patients with a
mutation in the gamma-glutamyl carboxylase (GGCX) gene
develop PXE-like symptoms [18]. GGCX catalyzes the
vitamin K-dependent carboxylation of glutamate residues to
calcium-binding gamma-glutamate (Gla) residues. During
this reaction, the hydroquinone form of vitamin K is
oxidized to its epoxide form. A small number of proteins
require γ-carboxylation for their activity. This group
includes several clotting factors as well as proteins involved
in calcification, such as matrix Gla-protein (MGP). MGP is
an inhibitor of tissue calcification [19]. Interestingly,
carboxylation of MGP was found to be reduced in PXE
patients [20, 21] and in the Abcc6
−/− mouse [22]. Recently,
Vanakker et al. [21] reported that PXE patients have
reduced vitamin K serum levels.
These data suggest that PXE symptoms are caused by a
local deficiency in vitamin K-dependent protein carboxyl-
ation. They support the “PXE-K hypothesis” [23], which
postulates that vitamin K (or a precursor of vitamin K) is
the substrate of the ABCC6 pump. It is known that vitamin
K, once it is taken up by the digestive system and brought
into the blood, is avidly taken up by the liver [24]. Here, it
can be used in the production of clotting factors. According
to the PXE-K hypothesis, ABCC6 protein exports vitamin
K (precursor) from the hepatocyte back into the blood-
stream. This will carry it to the periphery, where vitamin K
dependent γ-carboxylation of MGP prevents calcification.
Inactivation of ABCC6 would thus lead to shortage of
vitamin K in extra-hepatic tissues and failure to prevent
spontaneous calcification in these tissues.
The PXE-K hypothesis implies that providing the
periphery with functional vitamin K will prevent PXE. In
the present study, we tested this hypothesis by supple-
menting vitamin K to the animal model for PXE, the
Abcc6
−/− mouse [7]. A high dose of vitamin K was added
to the food, aiming to achieve high blood levels, which
would allow for a sufficient amount of vitamin K to
bypass the liver and reach the periphery. Vitamin K is a
group name for several structurally related molecules,
including phylloquinone (vitamin K1) and menaquinones
(K2 vitamins) [24]. Menaquinones (MK) are classified by
the length of their aliphatic side chain (MK-n). We chose
MK-7 for the dietary supplementation. While all forms of
vitamin K serve as a co-factor in the γ-carboxylation of
glutamate, MK-7 has a relatively long half-life (3 days) in
the blood [25, 26] suggesting that this form of K is apt to
escape rapid sequestration by the liver and reach extra-
hepatic, peripheral tissues. As biomarker for PXE symp-
toms in the mouse, we chose the mineralization of the
connective tissue capsule surrounding the blood sinus at
the base of the whiskers [27]. Mineralization was
m o n i t o r e di nv i v ob yX - r a ym i c r o - c o m p u t e dt o m o g r a p h y
(micro-CT). After a 3-month diet, mice were sacrificed,
and vitamin K content and tissue distribution were
determined.
Materials and methods
Mice
Abcc6
−/− mice were generated in a hybrid background of
C57BL/6 and 129/Ola and then backcrossed to C57BL/6
[7]. In the present study, we used mice that had been
backcrossed to C57BL/6 for ten generations. Abcc6
proficient (
+/+) littermates and pure C57BL/6 mice were
used as wt control mice. Mice were bred in our animal
facilities and kept in 12-h light–dark cycle of 50–80 lx
with water and food (Teklad 2918, Harlan Teklad,
Madison, WI) ad libitum. All animal studies were
approved by an independent animal ethical committee
under Dutch law.
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We designed two diets. One diet contained vitamin K in the
minimum dose required (MDR) (1×MK-7 diet), the other
100 times as much (100×MK-7 diet). The diets were made
by mixing MK-7 (Kind gift of J-Oil Mills, Nakashinden,
Fukuroi City, Japan; dissolved in sunflower oil) with a
mouse food lacking vitamin K (diet #4165.00, in powder
form, Arie Blok Diervoeding, Woerden, NL). The MDR for
rodents is about 0.25–0.5 μg/g food [28], based on blood
coagulation. Our diets contained 0.25 μg MK-7 (1×MDR)
or 25 μg MK-7 (100×MDR) per gram food.
Mice were divided into two equal groups of five
Abcc6
−/− and six wt mice (four Abcc6
+/+ and two C57BL/
6). One group received the 1×MK-7 food, the other the
100×MK-7 food. The food was provided ad libitum. The
diet started at 1 year of age and lasted for 3 months.
In vivo measurement of calcification in the muzzle
Abcc6
−/− mice develop calcification in the capsule sur-
rounding the blood sinus at the base of the whiskers [8]. We
in vivo monitored development and progression of this
calcification by micro-CT scans of the snout using a
Skyscan 1076 (SkyScan, Kontich, Belgium). Scans were
made using a 1-mm Al filter, the source set at 40 kV with a
current of 250 μA and a rotation step of 1.5°. During the
scan, mice were anaesthetized by isoflurane inhalation, and
the condition was monitored visually using a camera and by
measuring the rhythm of breathing. A scan of the muzzle
area took about 10 min. Scans were done once a month.
The first one was done at the start of the diet. After
3 months, the experiment was stopped.
From the scans, a 3D reconstruction of the snout was
made resulting in datasets with an isotropic voxel size of
35 μm using software supplied with the scanner. In these
reconstructions, both normal calcifications of skull and
teeth and ectopic calcification of blood sinuses were
clearly visible. Using an in-house-made Matlab software
tool (Matlab r2007b, The Mathworks, Natick, MA,
USA), calcification of skull and teeth was removed
automatically from the datasets. The remaining patholog-
ical calcification in sinus capsules was quantified by
assessing total mineralized volume after applying a
density threshold. The fixed threshold was chosen such
that the dynamics in sinus calcification were optimally
represented.
Ex vivo measurement of calcification in the kidney
Abcc6
−/− mice spontaneously develop calcification in the
walls of arteries in the kidney cortex [7, 29]. This vascular
calcification phenotype was quantified ex vivo, in
paraformaldehyde-fixed and paraffin-embedded kidneys
by two methods: micro-CT and histology.
Kidneys were scanned in a Skyscan 1076 micro-CT
scanner (Skyscan, Kontich, Belgium) using a 0.5-mm Al
filter,thesourcesetat55kV and181μAandarotationstepof
0.5°, resulting in datasets with a 9-μm isotropic voxel size.
After manually removing calcification in pelvis and tubules
from the images, the total volume of the calcifications in the
renal cortex was automatically determined using Matlab.
Next, sagittal sections of 6 μm were cut of the kidney,
and five sections per mouse, each separated by 180 μm,
were stained for calcification according to von Kossa. In
these sections, we counted the number of von Kossa
positive blood vessel profiles in the kidney cortex and
calculated the average number per section [29]. Micro-
graphs were taken with a Zeiss Axioplan 2 (Carl Zeiss AG,
Germany) equipped with an Evolution MP camera (Media-
Cybernetics, Bethesda, USA) and Image-Pro Plus acquisi-
tion software (version 6, MediaCybernetics, Bethesda, MD,
USA).
Tissue collection
Mice were anaesthetized and sacrificed by cervical dislo-
cation. Several organs were collected and either fixed in 2%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, or
frozen in liquid N2 and stored at −20°C. For histopathology,
paraformaldehyde-fixed tissue was embedded in paraffin.
Sections were stained with haematoxylin–eosin and von
Kossa using standard procedures.
Vitamin K measurement
Concentrations of vitamin K (K1 and K2)w e r ea n a l y z e db y
HPLC as described previously [30]. Briefly, part of the tissue
was weighed and homogenized in ethanol/water (v/v)a ta
ratio 1:2 using a blender (Ultra Turrax, Janke and Kunkel,
Staufen, Germany). Homogenized samples were supple-
mented with vitamin K1 (25) (GLSynthesis, Worcester,
USA) as an internal standard, extracted with four volumes
of n-hexane and pre-purified on silica columns. Quantifica-
tion of vitamin K was performed by RP-HPLC using
fluorescence detection after post-column reduction on a zinc
column (Riedel-DeHaën, Seelze, Germany) at 40°C. The
mobile phase consisted of ethanol/acetonitrile/reduction
buffer/water at a ratio (v/v) of 360:90:4:3 and was degassed
continuously with helium. Reduction buffer contained: 1 M
ZnCl2, 1 M NaOAc and 1 M AcOH in MeOH.
Statistics
In order to analyze dynamics of muzzle calcification during
the diet period we performed regression analysis for each
J Mol Med (2011) 89:1125–1135 1127mouse with either the actual calcification value or the log-
transformed calcification as dependent variable and diet
duration as independent variable in SPSS (version 16). The
R
2 adjusted of the linear and logarithmic regression was
calculated to assess the quality of the fit. To formally
describe the relation between calcification, diet and time
(diet duration), we performed a linear mixed model analysis
(in SPSS, version 16). The following parameters were
included in the model: the log of the volume of ectopic
calcification, measured by micro-CT, as dependent variable,
diet as factor and time (diet duration) as covariate. Fixed
effects in the analysis were diet, time and their interaction.
The analysis was performed with a random intercept (to
account for difference in start position) and random slope
(to account for difference in slope) per mouse. Statistical
analysis of the effect of MK-7 supplementation on kidney
cortex calcification was done with Student’s t test.
The effect of diet and genotype on tissue levels of
various vitamin K forms was analyzed by ANOVA in
SPSS (version 18) with vitamin K level as dependent
variable and diet and genotype as fixed factors. Since
Levene’s homogeneity test for equality of variances
indicated that variances were often unequal between the
groups, this ANOVA was performed on rank-transformed
data. Missing measurement values (presumably below
detection limit) were not included in the ranking. The
variance in the rank-transformed data was homogeneous
(Levene’st e s t ) .
Results
Dietary vitamin K supplementation
To examine the effect of supplemental vitamin K on the
PXE phenotype, we prepared two diets differing in vitamin
K content (1×MK-7, 100×MK-7), fed these for 3 months to
Abcc6
−/− and wt mice and monitored calcification in the
animals. Vitamin K was supplied as MK-7. The diets did
not cause overt discomfort to the mice. One mouse died
during the experiment, 1 month before the end of the diet
period. This was an Abcc6
−/− mouse on the 100×MK-7 diet.
The cause of death was not determined.
Effect of dietary vitamin K supplementation on calcification
in the muzzle
A prominent feature of the pathology of Abcc6
−/− mice is
spontaneous calcification of the capsule surrounding the
blood sinus at base of the whiskers [8]. Mice have 25–27
large whiskers on each muzzle, arranged in five rows of 5–
7 whiskers each [31]. We monitored the ectopic minerali-
zation in this tissue in vivo by micro-CT of the snout.
Micro-CT scans of wt mice did not show any calcifica-
tion of whisker sinus capsules at any time and dietary
regime. In contrast, all Abcc6
−/− mice had calcifications
already at the start of the diet (Fig. 1). These consisted of
shell-shaped calcifications of the whisker sinus capsule
(Fig. 2). Not all whisker sinus capsules were mineralized at
this stage. Follow-up scans showed a clear progression of
the calcification (Fig. 3). Both number of capsules affected
and extent of calcification in each capsule increased during
the diet period.
To quantify the ectopic calcification, we used the 3D
reconstructed micro-CT image of the snout, applied a
density threshold for calcification, removed the dense
signal of skull and teeth and calculated the volume of the
remaining density as representing the ectopic calcification
of the whisker capsule. Graphs of changes in calcification
volume over time are shown in Fig. 4. The graphs for the
individual mice illustrate the large individual differences.
The mice which we had assigned to the 1×MK-7 diet group
happened to have slightly more calcification at the start of
the diet than the mice on the 100×MK-7 diet. Please note
that calcification increased during the diet period in all
mice, in both diet groups. Regression analysis indicated that
progression of calcification during the diet period is well
described by an exponential model (log calcification
volume vs. time, average R
2 adjusted=0.94) or a linear
model (calcification volume vs. time, average R
2 adjusted=
0.93). Calcification volume increased considerably (3–4-
fold) in both diet groups over the 3-month diet period.
To formally describe the relation between volume of
ectopic calcification, diet and time (diet duration), we
performed a linear mixed model analysis with the log of the
calcification as dependent variable. The analysis showed that
calcification increased with time (P=0.001), but this progres-
sion was not dependent on diet (P interaction=0.976).
In summary, our in vivo measurements showed that the
100-fold increase in dietary MK-7 had no significant effect
on the pace of mineralization in whisker sinus capsules of
Abcc6
−/− mice.
Effect of dietary vitamin K supplementation on calcification
in the kidney
Calcification of walls of arteries is an important clinical
feature of PXE. In the Abcc6
−/− mouse, this phenotype is
particularly prominent in the kidney cortex. We visualized
this calcification ex vivo by two methods: First, micro-CT
scans were made of the isolated kidney. Next, the kidney
was sectioned, and a sample of sections was stained for
calcification by von Kossa.
While wt mice had no distinct renal cortex calcifications,
all Abcc6
−/− mice showed mineralization of arteries in the
cortex (Fig. 5). Calcification was quantified by measuring
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micro-CT, and secondly, by counting the number of
calcified profiles in the histological sections. The correla-
tion between the outcomes of both methods was high: a
correlation coefficient of 0.98 was found for calcification in
the Abcc6
−/− mice. To determine the effect of diet on
calcification in Abcc6
−/− mice, we applied Student’s t test:
no significant difference was found (P values 0.47 and 0.31
for histology and micro-CT, respectively; Fig. 5).
Hepatic vitamin K levels
To determine whether Abcc6 genotype and dietary MK-7
concentration influence uptake and tissue distribution of
vitamin K, we sacrificed the mice at the end of the 3-month
diet period and measured vitamin K levels in liver and
several extra-hepatic tissues. Please note that the mice had
received standard rodent chow until the start of experimen-
tal diets. During the experiment, they received vitamin K
only in the form of MK-7.
Liver tissue samples were measured for vitamin K1 and
for MK-4, MK-6 and MK-7. Measurable levels of K-
vitamers were found in liver samples of most wt and
Abcc6
−/− mice on 100×MK-7 diet. However, analysis of
liver samples of mice on the 1×MK-7 diet often gave no
measurable outcome, possibly because vitamin K levels in
these samples were below detection threshold. For example,
in the 1×MK-7 diet group, we obtained measurable MK-7
levels in only one out of six wt mice and in one out of five
Abcc6
−/− mice.
Figure 6 shows the measured vitamin K levels in the
liver as function of diet and Abcc6 genotype. In view
of missing (presumably below detection limit) data
points of the 1×MK-7 group, this plot underestimates
the effect of supplementation. Nonetheless, it suggests
that dietary MK-7 supplementation increased both MK-4
and MK-7 levels in liver. ANOVA indicated that MK-7
a n dM K - 4l e v e l sd e p e n d e do ns u p p l e m e n t a t i o n( P=
0.028 and 0.025, respectively) but not on genotype
(Table 1). Analysis of the effect of supplementation in
Abcc6
−/− mice separately did not yield significance,
possibly because of the missing data points in the
1×MK-7 diet group. For MK-6 and K1,n oe f f e c to f
supplementation was apparent.
Fig. 1 In vivo micro-CT imag-
ing of calcification in the muz-
zle. X-ray image and cross
sections of the 3D reconstructed
micro-CT image of the rostral
part of the head of a wt (left) and
Abcc6
−/− (right) mouse. Skull
and teeth are clearly visible,
both in wt and Abcc6
−/− mouse.
In addition, the Abcc6
−/− mouse
has shell-shaped calcified pro-
files (arrows) in the muzzles as
illustrated by the cross-sections.
Coloured lines indicate positions
of the cross-sectional planes
Fig. 2 a Micro-CT scan of an
Abcc6
−/− mouse muzzle show-
ing shell-shaped calcifications. b
Paraffin section of the muzzle of
an Abcc6
−/− mouse (aged
9 months; 1×MK-7diet) stained
with von Kossa localizes these
calcifications (black) to the
connective tissue capsule of the
blood sinus of the whisker hair
follicle. c Whisker follicle of a
wt mouse (aged 8 months;
1×MK-7 diet) without calcifica-
tion. Scale bar is 200 μm
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TodeterminethedistributionofvitaminKtoextra-hepatictissues,
we analyzed samples of kidney, heart, brain and skin for K1,M K -
4, MK-5, MK-6 and MK-7. The vitamers K1,M K - 5a n dM K - 6
werehardlydetectedinoursamples,andnoconclusiononeffect
of diet or genotype on their distribution was drawn.
The amount of MK-4 in the tissue samples generally
sufficed for quantification. In wt mice, the100-fold increased
dietary MK-7 resulted in a 5–10-fold increased level of MK-4
in all extra-hepatic tissues (Fig. 7). Abcc6
−/− mice had similar
MK-4 tissue levels as wt mice. As in wt mice, the 100×MK-
7 diet increased MK-4 levels in skin, heart and brain of
Abcc6
−/− mice (Fig. 7). ANOVA (Table 1) indicated that
MK-4 levels depended on diet, but not on Abcc6 genotype
(except possibly for the skin, where MK-4 levels surprisingly
tended to be higher in Abcc6
−/− mice than wt mice).
Importantly, ANOVA showed that the effect of diet on
vitamin K tissue levels was not dependent on functional
Abcc6 (Table 1, P values of interaction diet × genotype).
Since both calcification and vitamin K levels varied
greatly between mice, we examined whether a correlation
existed between muzzle calcification and vitamin K tissue
level. No significant correlation was found (for example,
for skin MK-4 level: Pearson’s r=−0.056, P=0.928).
Measurements of extra-hepatic MK-7 levels were less
clear (Fig. 8, Table 1). The amount of MK-7 was often
below detection level or highly variable. A significant
increase in MK-7 as a result of dietary supplementation was
only found in skin (Table 1).
Discussion
The PXE-K hypothesis [23] postulates that vitamin K
(precursor) is the substrate of ABCC6. If true, this would
provide a rationale for an easily applicable therapy, i.e. vitamin
K supplementation. We performed a dietary supplementation
experiment using the PXE mouse model to test hypothesis as
well as potential therapy. Our results do not lend support to the
Fig. 3 Cross sections from micro-CT scans of an Abcc6
−/− mouse (on
1×MK-7 diet) showing the in vivo progression in calcification of
whisker sinuses, from the start of the diet (0 months) until the end
(3 months). Arrows point at whisker sinuses that are calcified after
3 months, whereas they were not calcified at the start of the diet
Fig. 4 Progression of calcification in the muzzles of Abcc6
−/− mice
from the start of the diet (time=0) to the end, after 90 days. Coloured
lines in the two graphs on the left depict the mineralization process in
the individual mice. The graph on the right shows the averages per
diet group (with missing values imputed). The 1×MK-7 diet group
had, by chance, a slightly higher calcification at the start of the diet.
Importantly, calcification progressed in all mice and no difference in
the pace of calcification was noticed between the diets (for statistics,
see Results)
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pathology (calcification) by feeding Abcc6
−/− mice extra
vitamin K. Secondly, vitamin K tissue levels did not depend
on Abcc6 genotype. Thirdly, no correlation was found
between ectopic calcification and vitamin K tissue levels.
Dietary MK-7 supplementation did not reduce ectopic
calcification
To test the PXE-K hypothesis, we employed the Abcc6
−/−
mouse model for PXE [7, 8]. As measure of PXE
pathology, we analyzed calcification in the connective
tissue capsule that surrounds the blood sinus at the base
of the whiskers [8]. This feature of Abcc6
−/− mice has been
used as a biomarker for ectopic mineralization in a number
of studies [27]. An important advantage of this parameter is
that it can be visualized and measured in vivo by micro-CT,
as demonstrated in this study. This enabled us to monitor
the mineralization process in individual mice during the
diet period. This is particularly relevant, since inter-animal
variation in the extent of calcification can be large, which
can hamper statistical analysis when only endpoints are
Fig. 5 Effect of vitamin K supplementation on calcification in arteries
in the kidney cortex. a–d Kidney sections of wt (a, c) and Abcc6
−/−
mice (b, d) on 1×MK-7 (a, b) or 100×MK-7 diet (c, d). Von Kossa
staining shows calcification (black deposits) in walls of arteries in the
cortex of Abcc6
−/− mice on either diet. No calcifications were
observed in wt mice. Cortex is on the right, medulla on the left. Bar
is 200 μm. e Effect of diet on calcifications in arteries in the kidney
cortex in Abcc6
−/− mice, assessed by histology. Histograms represent
mean number ± standard deviation (s.d.) of calcified profiles per
sagittal kidney section. Diet did not cause a significant difference in
calcification (p=0.47, Student’s t test). f Effect of diet on calcifications
in arteries in the kidney cortex in Abcc6
−/− mice, assessed by micro-
CT. Histograms represent average volume (±s.d.) of calcifications per
kidney. Diet did not cause a significant difference in calcification (p=
0.31, Student’s t test)
Fig. 6 Vitamin K levels (±s.d.)
in the liver as function of diet
and Abcc6 genotype. Please note
that some data points (mainly in
the 1×Mk-7 diet group) were
missing (as indicated by an
absence of an error bar) pre-
sumably because the levels were
below detection threshold
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muzzle calcification and does not rely on sectioning and
sampling as histological techniques do.
Our in vivo measurements clearly showed that a 100-fold
increased MK-7 concentration in the diet did not change the
paceofcalcificationofwhiskersinuscapsules.Toconfirmand
extend these findings, we measured ex vivo the calcification
in arteries in the kidney cortex. This vascular calcification
phenotype was not affected by MK-7 supplementation either.
It may be argued that we started the dietary intervention
too late to obtain an effect of vitamin K. Supplementation
of vitamin K may have effect only in initial stages and may
not affect pathology once calcification has started. Howev-
er, micro-CT scans taken before the start of the diet showed
that not all whisker sinuses had begun to mineralize at that
point. During our diet period, clearly both volume and
number of calcified whiskers increased (Fig. 3). Addition-
ally, in rats suffering from medial elastocalcinosis, 6 weeks
of vitamin K treatment resulted in some 40% reduction of
preformed calcifications [32]. Taken together, our conclu-
sion of lack of an effect of vitamin K probably holds true
for both ongoing mineralization and de novo mineralization
of whiskers capsules in PXE.
In addition, the objection may be raised that the diet was
not given long enough to take effect. We consider this to be
unlikely. The diet clearly increased tissue levels of vitamin K,
measured at the end of the diet. When we compare the
progress in calcification in the three intervals between the
micro-CT scans, we did not notice a slower pace of
calcification in the 100×MK-7 diet group in the last interval
(Fig.4). In addition, in a previous animal study, it was shown
that a 4-week period of high vitamin K2 intake was sufficient
to inhibit medial calcifications induced by coumarins [30].
MK-7 supplementation increased MK-4 tissue levels,
irrespective of Abcc6 genotype
In wt mice, the 100×MK-7 diet caused higher levels of
MK-7 in liver and skin. In other tissues, no increased MK-7
levels were found. Interestingly, MK-7 supplementation
also raised MK-4 levels in the liver and in all extra-hepatic
tissues investigated (skin, kidney, heart and brain). These
All mice Wild type Abcc6
−/−
Diet Genotype Interaction diet×genotype Diet Diet
Liver MK-4 0.026 0.823 0.566 0.026 0.260
MK-7 0.050 0.914 0.592 0.056 0.195
Kidney MK-4 0.006 0.597 0.851 0.002 0.228
MK-7 –
a –
a –
a –
a –
a
Skin MK-4 0.000 0.006 0.664 0.000 0.030
MK-7 0.013 0.980 0.482 0.002 –
a
Heart MK-4 0.000 0.069 0.885 0.002 0.016
MK-7 0.801 0.995 0.506 0.558 0.687
Brain MK-4 0.000 0.204 0.805 0.003 0.001
MK-7 –
a –
a –
a –
a –
a
Table 1 ANOVA of the effect of
diet and Abcc6 genotype on
vitamin K tissue levels
The analysis compared two
diets with 100-fold difference
in MK-7 content (P values of
ANOVA on rank-transformed
data, see M&M. P values <
0.05 are italicized)
aNot enough data points
Fig. 7 MK-4 levels (±s.d.) in
liver and extra-hepatic tissues as
function of diet and genotype.
The 100×MK-7 diet increased
MK-4 tissue levels both in wt
and Abcc6
−/− mice (for statistics,
see Table 1)
1132 J Mol Med (2011) 89:1125–1135MK-4 measurements indicate that at least part of the
supplied MK-7 is converted into MK-4. Thijssen et al.
[33] previously demonstrated that all K vitamins can be
converted into MK-4 via the intermediate product menadi-
one (K3). The side-chain removal most likely takes place in
the enterocytes, after which the circulating K3 can be taken
u pa n dp r e n y l a t e dt oM K - 4l o c a l l y .I na d d i t i o n ,o u r
observation that the 100×MK-7 diet increased MK-7 (and
not MK-6 or MK-5) in skin and liver suggests that MK-7 is
also taken up without being converted.
According to the PXE-K hypothesis, Abcc6 transports
vitamin K from the hepatocyte cytoplasm into the blood-
stream. Since the liver efficiently clears vitamin K from the
circulation, this transport is essential for the supply of extra-
hepatic tissues with vitamin K. On the basis of the PXE-K
hypothesis, we expected Abcc6
−/− mice to have lower extra-
hepatic vitamin K levels than wt mice. However, we found
that vitamin K levels were not reduced in Abcc6
−/− mouse
tissues. In the Abcc6
−/− skin, MK-4 level even appeared to be
increased. Whether this particular finding occurred by
chance or has biological significance is not known. In a
pilot experiment preceding this study, we compared vitamin
K levels between five wt and five Abcc6
−/− male mice of
7 months old. No difference was found between the skin
levels of K vitamins, including MK-4 (data not shown).
Overall, the data suggest that Abcc6 genotype has no
influence on MK-4 tissue levels. We also found that it had
no influence on the increase in MK-4 levels that occurred by
the dietary MK-7 supplementation. These findings suggest
that, contrary to the PXE-K hypothesis, Abcc6 has no role in
transport of vitamin K to extra-hepatic tissues.
Increased vitamin K tissue levels did not slow down
mineralization
Vitamin K is needed as co-factor in the γ-glutamyl
carboxylation-mediated activation of various proteins [34].
The calcification inhibitor MGP was found to be
uncarboxylated and thus inactive in PXE patients [20].
Even though we failed to demonstrate a role of Abcc6 in
transport of vitamin K, it is still possible that vitamin K
supplementation would increase MGP carboxylation and,
in this way, alleviate PXE symptoms. Our dietary regime
significantly (5–10-fold) increased MK-4 levels in extra-
hepatic tissue, both in wt and in Abcc6
−/− mice. Yet, the
increased MK-4 concentrations did not reduce ectopic
calcification. This suggests that in our Abcc6
−/− mice,
local vitamin K concentration is not the limiting factor in
preventing mineralization of connective tissue. This
conclusion is supported by the fact that no correlation
was found between MK-4 content and muzzle calcifica-
tion in individual mice. In addition, the findings suggest
that other forms of administration such as parental or
intravenous administration may equally fail to halt this
pathology.
In order to investigate directly whether vitamin K
supplementation had changed the local status of MGP, we
performed immunohistochemistry with conformation-
specific antibodies for either ucMGP or cMGP on sections
of aorta and muzzle. However, no clear immunostaining
could be observed in wt or in Abcc6
−/− tissue. Apparently,
our material was not suited for this technique (e.g. caused
by poor antigen preservation). The local carboxylation
status of MGP during our dietary regime thus remained
undetermined.
Aetiology of PXE?
Previous studies strongly suggested that PXE symptoms
a r ec a u s e db yl o c a lt i s s u ed e f i c i e n c yi nv i t a m i nK -
dependent protein carboxylation. These indications in-
cluded (1) PXE-like features in patients with GGCX
mutations [18], (2) reduced γ-carboxylation of MGP in
PXE patients [20] and (3) reduced serum levels of vitamin
Fig. 8 MK-7 levels (±s.d.) in
liver and in extra-hepatic tissues
as function of diet and genotype.
MK-7 levels were highly vari-
able. No differences were ob-
served between the genotypes.
A statistically significant effect
of diet was found for skin and
liver (for statistics, see Table 1)
J Mol Med (2011) 89:1125–1135 1133K in PXE patients [21]. The hypothesis that Abcc6
transports vitamin K and thereby distributes vitamin K to
extra-hepatic tissues offers an elegant explanation for
these data.
Yet, in the present study, we found no indications that
Abcc6 plays a role in vitamin K transport and
distribution. Certainly, our study has limitations. Some
of these were already discussed above. We can add here
that our study was done in the mouse model for PXE
and that there may be (yet unknown) differences
between mouse and man in vitamin K trafficking.
Nonetheless, with the present knowledge, the Abcc6
−/−
mouse appears to be a valid PXE model for our current
studies: It resembles PXE in genotype and phenotype [7]
including the undercarboxylation of MGP [22]. Moreover,
as for vitamin K trafficking in mice, vitamin K tissue
levels increased as a result of MK-7 supplementation, both
in wt and in Abcc6
−/− mice. Therefore, our conclusions
obtained with the PXE mouse model likely have validity
for the aetiology of PXE. They do not support the
hypothesis of deficient vitamin K transport as a cause of
PXE. Furthermore, while this study was under review, Li
et al. [35] and Brampton et al. [36] reported that neither
intravenous administration of a vitamin K conjugate
(menadione gluthatione conjugate) nor dietary supplemen-
tation with MK-4 or K1 counteracted ectopic mineraliza-
tion in the Abcc6
−/− mouse.
Other explanations must now be considered for the
reduced vitamin K-dependent protein carboxylation in
PXE tissues. Instead of vitamin K, Abcc6 may
transport another substance that directly or indirectly
affects γ-carboxylation. For example, since it has been
reported that increased oxidative stress occurs in PXE
[37–40], it could be that Abcc6 transports a substance
that affects oxidative stress levels. Increased numbers of
free radicals will scavenge the reduced form of vitamin
K and thereby prevent the γ-carboxylation. In this way,
not amount but rather redox status of vitamin K
determines PXE. Differential measurement of the redox
forms of vitamin K in Abcc6
−/− mouse tissue may solve
this issue.
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